Completed NA INTERVENTIONAL 2-arm NCT00255840

Evaluation of Two Anti-HIV Treatment Strategies in Resource-Limited South African Communities

Safeguard the Household - A Study of HIV Antiretroviral Therapy Treatment Strategies Appropriate for a Resource Poor Country

Sponsor: CIPRA SA

Conditions HIV Infections

Interventions Efavirenz Lamivudine Lopinavir/Ritonavir Monitoring by an HIV-trained medical doctor Monitoring by an HIV-trained primary care nurse Nevirapine Stavudine

Updated 7 times since 2017 Last updated: Jun 17, 2011 Started: Jul 31, 2006 Primary completion: Jan 31, 2009 Completion: Jan 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates HIV Infections and is currently completed. CIPRA SA leads this study, which shows 7 recorded versions since 2006 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Dec 2021 — Jul 2024 [monthly]

Completed NA
Jan 2021 — Dec 2021 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA

▶ Show 2 earlier versions

Feb 2017 — Jun 2018 [monthly]

Completed NA
Jan 2017 — Feb 2017 [monthly]

Completed NA

First recorded

Jul 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

CIPRA SA
National Institute of Allergy and Infectious Diseases (NIAID)

Data source: CIPRA SA

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.